Stockreport

Agenus: A Would-Be Rockstar Held Back By Middling Financials [Seeking Alpha]

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF The company's phase 2 trial of botensilimab in colorectal cancer is fully enrolled, with a mid-year 2024 readout likely. AGEN has various strategies to raise cash, su [Read more]